Skip to content
IMKELDI Oral Solution by Shorla Oncology
  • IMKELDI v. Imatinib Tablets
  • Package Insert
  • Ordering
  • Patient Instructions
  • Patient Assistance

Director of Sales Operations

Read More

Director of Medical Affairs

Read More

IRELAND HQ:
Questum Acceleration Center,
Ballingarrane Science & Technology Park,
Clonmel, Co. Tipperary,
E91 V329, Ireland

SITEMAP
PRIVACY POLICY
Company number: 618033
©SHORLA ONCOLOGY® 2025

Shorla Pharma Ltd trading as Shorla Oncology®

 

All trademarks are the property of their respective owners.

US OFFICE:
245 Main St.,
2nd floor,
Cambridge,
MA 02142, USA

SITEMAP
PRIVACY POLICY
Company number: 618033
©SHORLA ONCOLOGY® 2025

© 2025 IMKELDI Oral Solution by Shorla Oncology • Built with GeneratePress
  • IMKELDI v. Imatinib Tablets
  • Package Insert
  • Ordering
  • Patient Instructions
  • Patient Assistance

Now approved for use in Pediatrics

  • Treatment of pediatric patients with polyarticular juvenile idiopathic arthritis (pJIA).
  • Treatment of pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen.

Please click here for the full Prescribing information, including Boxed Warning regarding embryo-fetal toxicity, hypersensitivity reactions, and severe adverse reactions.